Cargando…
GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH
GLP-1 is derived from intestinal L cells, which takes effect through binding to GLP-1R and is inactivated by the enzyme dipeptidyl peptidase-4 (DPP-4). Since its discovery, GLP-1 has emerged as an incretin hormone for its facilitation in insulin release and reduction of insulin resistance (IR). Howe...
Autores principales: | Li, Qiu-Xuan, Gao, Han, Guo, Yue-Xin, Wang, Bo-Ya, Hua, Rong-xuan, Gao, Lei, Shang, Hong-Wei, Lu, Xin, Xu, Jing-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450670/ https://www.ncbi.nlm.nih.gov/pubmed/34552561 http://dx.doi.org/10.3389/fendo.2021.721198 |
Ejemplares similares
-
Emerging Role of Caveolin-1 in GLP-1 Action
por: Puddu, Alessandra, et al.
Publicado: (2021) -
The beneficial metabolic actions of prolactin
por: Macotela, Yazmín, et al.
Publicado: (2022) -
Identification of ferroptosis-related genes in the progress of NASH
por: He, Linwei, et al.
Publicado: (2023) -
The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
por: Du, Haiyang, et al.
Publicado: (2022) -
Editorial: Immune mechanisms of inflammation in NASH
por: Hirsova, Petra, et al.
Publicado: (2022)